The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum

Fertility and Sterility

Volumn 92, Issue 5, 2009, Pages 1748.e1-1748.e4

  Marnitz, Simone ^a   Schmittel, Alexander ^a   Bolbrinker, Juliane ^a   Schmidt, Frank Peter ^b   Fons, Guus ^c   Kalache, Karim ^a   Schneider, Achim ^a   Köhler, Christhardt ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institut fur Medizinische Diagnostik   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

cervical cancer; pharmacokinetics; platinum based chemotherapy; Pregnancy; toxicity

Indexed keywords

CISPLATIN; DEXAMETHASONE; MANNITOL; ONDANSETRON;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; CANCER INVASION; CANCER STAGING; CASE REPORT; CESAREAN SECTION; CLINICAL EVALUATION; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FATIGUE; FEASIBILITY STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HYDRATION; IN VIVO STUDY; LAPAROSCOPIC SURGERY; LAPAROSCOPIC TRANSPERITONEAL PELVIC LYMPHADENECTOMY; MATERNAL SERUM; MULTIPLE CYCLE TREATMENT; NAUSEA; PELVIS LYMPHADENECTOMY; PLACENTAL TRANSFER; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TREATMENT DURATION; TUMOR BIOPSY; TWIN PREGNANCY; UMBILICAL CORD; UNIVERSITY HOSPITAL; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AMNIOTIC FLUID; ANTINEOPLASTIC AGENTS; CISPLATIN; FEASIBILITY STUDIES; FEMALE; FETAL BLOOD; HUMANS; LAPAROSCOPY; MATERNAL-FETAL EXCHANGE; MOTHERS; NEOPLASM STAGING; OSMOLAR CONCENTRATION; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY, MULTIPLE; TWINS; UTERINE CERVICAL NEOPLASMS;

EID: 70350572859     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.07.1000     Document Type: Article

References (29)

1. Cardonick E., and Iacobucci A. Use of chemotherapy during human pregnancy. Lancet 5 (2004) 283-291
2. Sadler L., and Sykes P. How little is known about cervical cancer in pregnancy?. Ann Oncol 16 (2005) 397-402
3. Al-Saleh E., Nandakumaran M., Al-Rashdan I., Al-Harmi J., and Al-Shammari M. Maternal-fetal transport kinetics of carboplatin in the perfused human placental lobule: in vitro study. J Matern Fetal Neonatal Med 20 (2007) 695-701
4. Marana H.R., de Andrade J.M., da Silva Mathes A.C., Duarte G., da Cunha S.P., et al. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy. Gynecol Oncol 80 (2001) 272-274
5. Benhaim Y., Pautier P., Bensaid C., Lhommé C., Haie-Meder C., and Morice P. Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression. Eur J Obstet Gynecol Reprod Biol 136 (2008) 267-268
6. Jones W.B., Shingleton H.M., Russell A., Fremgen A.M., Clive R.E., Winchester D.P., et al. Cervical carcinoma and pregnancy. A national patterns of care study of the American College of Surgeons. Cancer 77 (1996) 1479-1488
7. Bader A.A., Petru E., and Winter R. Long-term follow-up after neoadjuvant chemotherapy for high-risk cervical cancer during pregnancy. Gynecol Oncol 105 (2007) 269-272
8. Smith L.H., Dalrymple J.L., Leiserowitz G.S., Danielsen B., and Gilbert W.M. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol 184 (2001) 1504-1512
9. Duggan B., Muderspach L.I., Roman L.D., Curtin J.P., d'Ablaing III G., and Morrow C.P. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol 82 (1993) 598-602
10. Caluwaerts S., Van Calsteren K., Mertens L., Lagae L., Moerman P., Hanssens M., et al. Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int Gynecol Cancer 16 (2006) 905-908
11. Mir O., Berveiller P., Ropert S., Goffinet F., and Goldwasser F. Use of platinum derivatives during pregnancy. Cancer 113 (2008) 3069-3074
12. García-González J., Cueva J., Lamas M.J., Curiel T., Graña B., and López-López R. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy. Clin Transl Oncol 10 (2008) 375-376
13. Berveiller P., Adam J., and Mir O. Feasibility of platinum-based chemotherapy during pregnancy. Am J Obstet Gynecol 199 (2008) 21-22 author reply 22
14. Amant F., Van Calsteren K., Vergote I., and Ottevanger N. Gynecologic oncology in pregnancy. Crit Rev Oncol Hematol 67 (2008) 187-195
15. Palaia I., Pernice M., Graziano M., Bellati F., and Panici P.B. Neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer during pregnancy: a case report. Am J Obstet Gynecol 197 (2007) 5-6
16. Tewari K., Cappuccini F., Gambino A., Kohler M.F., Pecorelli S., and DiSaia P.J. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer 82 (1998) 1529-1534
17. Elit L., Bocking A., Kenyon C., and Natale R. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol 72 (1999) 123-127
18. Giacalone P.L., Laffargue F., Benos P., Rousseau O., and Hedon B. Cis-platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. Br J Obstet Gynaecol 103 (1996) 932-934
19. Arango H.A., Kalter C.S., Decesare S.L., Fiorica J.V., Lyman G.H., and Spellacy W.N. Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstet Gynecol 84 (1994) 665-668
20. Henderson C.E., Elia G., Garfinkel D., Poirier M.C., Shamkhani H., and Runowicz C.D. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol 49 (1993) 92-94
21. Koc O.N., McFee M., Reed E., and Gerson S.L. Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure. Eur J Cancer 30A (1994) 716-717
22. Köpf-Maier P. Stage of pregnancy-dependent transplacental passage of 195mPt after cis-platinum treatment. Eur J Cancer Clin Oncol 19 (1983) 533-536
23. Raffles A., Williams J., Costeloe K., and Clark P. Transplacental effects of maternal cancer chemotherapy. Case report. Br J Obstet Gynaecol 96 (1989) 1099-1100
24. Levine B.S., Preache M.M., and Pergament E. Mutagenic potential of cis-dichlorodiammine platinum II in rodents. Toxicology 17 (1980) 57-65
25. Zemlickis D., Klein J., Moselhy G., and Koren G. Cisplatin protein binding in pregnancy and the neonatal period. Med Pediatr Oncol 23 (1994) 476-479
26. Reece P.A., Stafford I., Davy M., and Freeman S. Disposition of unchanged cisplatin in patients with ovarian cancer. Clin Pharmacol Ther 42 (1987) 320-325
27. Li R.H., Tam W.H., Ng P.C., Mok T.S., Tam B., and Lau T.K. Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report. J Reprod Med 52 (2007) 575-576
28. Karam A., Feldman N., and Holschneider C.H. Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol 4 (2007) 375-380
29. Malfetano J.H., and Goldkrand J.W. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol 75 (1990) 545-547